Trial in progress: A study of roginolisib in combination with ruxolitinib in patients with myelofibrosis who are unresponsive to JAK inhibitors (HEMA-MED)Alessandro M. Vannucchi, Matteo Della Porta, Paola Guglielmelli et al.|Blood|2025Cited by 0